Literature DB >> 30530825

Galectin-9 reflects the interferon signature and correlates with disease activity in systemic autoimmune diseases. Response to: 'Biomarkers: to be or not to be' by Yavuz and Rönnblom.

Lucas L van den Hoogen1,2, Eefje H M van der Heijden3,2, Maarten R Hillen3,2, Jorre S Mertens3,2,4, Ruth D E Fritsch-Stork5,6, Timothy R D J Radstake3,2, Joel A G van Roon3,2.   

Abstract

Entities:  

Keywords:  antiphospholipid syndrome; autoimmune diseases; dermatomyositis; sjøgren's syndrome; systemic lupus erythematosus

Year:  2018        PMID： 30530825     DOI： 10.1136/annrheumdis-2018-214651

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.

Authors:  Naoki Matsuoka; Yuya Fujita; Jumpei Temmoku; Makiko Yashiro Furuya; Tomoyuki Asano; Shuzo Sato; Haruki Matsumoto; Hiroko Kobayashi; Hiroshi Watanabe; Eiji Suzuki; Hideko Kozuru; Hiroshi Yastuhashi; Kiyoshi Migita
Journal:  PLoS One       Date:  2020-01-27       Impact factor: 3.240

2.  Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.

Authors:  Thomas A Premeaux; Carlee B Moser; Ashley McKhann; Martin Hoenigl; Elizabeth I Laws; Draven L Aquino; Michael M Lederman; Alan L Landay; Sara Gianella; Lishomwa C Ndhlovu
Journal:  AIDS       Date:  2021-12-01       Impact factor: 4.632
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.